These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 25969908)
1. Osteopontin: a new facilitating factor in alopecia areata pathogenesis? Ganzetti G; Simonetti O; Campanati A; Giuliodori K; Scocco V; Brugia M; Tocchini M; Offidani A Acta Dermatovenerol Croat; 2015; 23(1):19-22. PubMed ID: 25969908 [TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of diphenylcyclopropenone alone or in combination with anthralin in the treatment of chronic extensive alopecia areata: a retrospective case series. Durdu M; Özcan D; Baba M; Seçkin D J Am Acad Dermatol; 2015 Apr; 72(4):640-50. PubMed ID: 25653027 [TBL] [Abstract][Full Text] [Related]
3. Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients. Chiang KS; Mesinkovska NA; Piliang MP; Bergfeld WF J Investig Dermatol Symp Proc; 2015 Nov; 17(2):50-5. PubMed ID: 26551948 [TBL] [Abstract][Full Text] [Related]
4. Videocapillaroscopic pattern of alopecia areata before and after diphenylciclopropenone treatment. Ganzetti G; Campanati A; Simonetti O; Cataldi I; Giuliodori K; Offidani AM Int J Immunopathol Pharmacol; 2011; 24(4):1087-91. PubMed ID: 22230416 [TBL] [Abstract][Full Text] [Related]
5. Gene expression of osteopontin in alopecia areata? A case-controlled study. Rateb AA; Mohammed FN; Sayed KS; Hegazy RA; Al Agha RR; Rashed LA; Sayed SS Skin Pharmacol Physiol; 2015; 28(2):84-90. PubMed ID: 25322767 [TBL] [Abstract][Full Text] [Related]
6. A randomized trial of diphenylcyclopropenone (DPCP) combined with anthralin versus DPCP alone for treating moderate to severe alopecia areata. Ghandi N; Daneshmand R; Hatami P; Abedini R; Nasimi M; Aryanian Z; Vance TM Int Immunopharmacol; 2021 Oct; 99():107971. PubMed ID: 34298402 [TBL] [Abstract][Full Text] [Related]
7. Topical immunotherapy of severe alopecia areata with diphenylcyclopropenone (DPCP): experience in an Iranian population. Aghaei S BMC Dermatol; 2005 May; 5():6. PubMed ID: 15918897 [TBL] [Abstract][Full Text] [Related]
8. Diphenylcyclopropenone plays an effective therapeutic role by up-regulating the TSLP/OX40L/IL-13 pathway in severe alopecia areata. Gong Y; Luo L; Li L; He X; Lu W; Sha X; Mao Y Exp Dermatol; 2021 Feb; 30(2):278-283. PubMed ID: 33325128 [TBL] [Abstract][Full Text] [Related]
9. Serum level of IL-4 predicts response to topical immunotherapy with diphenylcyclopropenone in alopecia areata. Gong Y; Zhao Y; Zhang X; Qi S; Li S; Ye Y; Yang J; Caulloo S; McElwee KJ; Zhang X Exp Dermatol; 2020 Mar; 29(3):231-238. PubMed ID: 30047620 [TBL] [Abstract][Full Text] [Related]
10. Expression of vascular endothelial growth factor, apoptosis inhibitors (survivin and p16) and CCL27 in alopecia areata before and after diphencyprone treatment: an immunohistochemical study. Simonetti O; Lucarini G; Bernardini ML; Simoncini C; Biagini G; Offidani A Br J Dermatol; 2004 May; 150(5):940-8. PubMed ID: 15149507 [TBL] [Abstract][Full Text] [Related]
11. DPCP for the treatment of alopecia areata. Bolduc C; Shapiro J Skin Therapy Lett; 2000; 5(5):3-4. PubMed ID: 10854342 [TBL] [Abstract][Full Text] [Related]
12. Effects of diphencyprone on expression of Bcl-2 protein in patients with alopecia areata. Pazoki-Toroudi H; Ajami M; Babakoohi S; Khaki L; Habibey R; Akhiani M; Seirafi H; Firooz A Immunopharmacol Immunotoxicol; 2010 Sep; 32(3):422-5. PubMed ID: 20095801 [TBL] [Abstract][Full Text] [Related]
13. Diphenylcyclopropenone (diphencyprone, DPCP) in the treatment of chronic severe alopecia areata (AA). Galadari I; Rubaie S; Alkaabi J; Galadari H Eur Ann Allergy Clin Immunol; 2003 Dec; 35(10):397-401. PubMed ID: 14768526 [TBL] [Abstract][Full Text] [Related]
14. Topical immunotherapy with diphenylcyclopropenone in the treatment of chronic extensive alopecia areata. Sotiriadis D; Patsatsi A; Lazaridou E; Kastanis A; Vakirlis E; Chrysomallis F Clin Exp Dermatol; 2007 Jan; 32(1):48-51. PubMed ID: 17004987 [TBL] [Abstract][Full Text] [Related]
15. Letter: Alopecia areata during ustekinumab administration: Co-existence or an adverse reaction? Verros C; Rallis E; Crowe M Dermatol Online J; 2012 Jul; 18(7):14. PubMed ID: 22863636 [TBL] [Abstract][Full Text] [Related]
16. A prospective comparative study of two regimens of diphenylcyclopropenone (DPCP) in the treatment of alopecia areata. Al Bazzal A; Hatami P; Abedini R; Etesami I; Ayanian Z; Ghandi N Int Immunopharmacol; 2021 Dec; 101(Pt B):108186. PubMed ID: 34710658 [TBL] [Abstract][Full Text] [Related]
17. Topical immunomodulation with diphenylcyclopropenone for alopecia areata: the Lebanese experience. El Khoury J; Abd-el-Baki J; Succariah F; Abbas O; Kibbi AG; Kurban M Int J Dermatol; 2013 Dec; 52(12):1551-6. PubMed ID: 24134785 [TBL] [Abstract][Full Text] [Related]
18. Alopecia areata with white hair regrowth: case report and review of poliosis. Jalalat SZ; Kelsoe JR; Cohen PR Dermatol Online J; 2014 Sep; 20(9):. PubMed ID: 25244170 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of diphenylcyclopropenone among Chinese patients with steroid resistant and extensive alopecia areata. Luk NM; Chiu LS; Lee KC; Chau CT; Lee VW; Chang M; Lam YK; Lee HC J Eur Acad Dermatol Venereol; 2013 Mar; 27(3):e400-5. PubMed ID: 23057682 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]